(Q40393916)

20 September 2017

1 reference

title

Con: tranexamic acid is not better than aprotinin in decreasing bleeding after cardiac surgery (English)

1 reference

20 September 2017

Con: Tranexamic acid is not better than aprotinin in decreasing bleeding after cardiac surgery (English)

1 reference

https://api.crossref.org/works/10.1016/1053-0770(94)90292-5

17 May 2024

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524720

17 May 2024

author name string

J. M. Murkin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524720

17 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7524720

17 May 2024

publication date

1 August 1994

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:1053077094902925?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/1053-0770(94)90292-5

https://api.elsevier.com/content/article/PII:1053077094902925?httpAccept=text/plain

17 May 2024

1 reference

https://api.crossref.org/works/10.1016/1053-0770(94)90292-5

Journal of Cardiothoracic and Vascular Anesthesia

17 May 2024

published in

1 reference

20 September 2017

volume

8

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

474-476

1 reference

Effect of aprotinin on need for blood transfusion after repeat open-heart surgery

20 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/1053-0770(94)90292-5

Effect of aprotinin on need for blood transfusion in patients with septic endocarditis having open-heart surgery

17 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/1053-0770(94)90292-5

Decreasing use of donated blood and reduction of bleeding after orthotopic heart transplantation by use of aprotinin

17 May 2024

6

1 reference

https://api.crossref.org/works/10.1016/1053-0770(94)90292-5

High-dose aprotinin therapy: a review of the first five years' experience

17 May 2024

7

1 reference

https://api.crossref.org/works/10.1016/1053-0770(94)90292-5

Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom

17 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/1053-0770(94)90292-5

Letter: Tranexamic acid and intracranial thrombosis

17 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/1053-0770(94)90292-5

Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study

17 May 2024

10

1 reference

https://api.crossref.org/works/10.1016/1053-0770(94)90292-5

Clinical application of inhibitors of fibrinolysis

17 May 2024

14

1 reference

https://api.crossref.org/works/10.1016/1053-0770(94)90292-5

Platelet-activating factor antagonists (BN 52021 and BN 50730) inhibit tumor necrosis factor-alfa-mediated cytotoxicity on murine L929 tumor cells

17 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/1053-0770(94)90292-5

Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery.

17 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/1053-0770(94)90292-5

Prevention of postbypass bleeding with tranexamic acid and epsilon-aminocaproic acid.

17 May 2024

19

1 reference

https://api.crossref.org/works/10.1016/1053-0770(94)90292-5

17 May 2024

Identifiers

1 reference

20 September 2017

1 reference